Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Rao Mulpuri, Andrzej Jakubowiak, Shaji Kumar, Sagar Lonial, and More

Premium

Provista Diagnostics, a developer of proteomics-based cancer tests, has appointed Rao Mulpuri as COO. Most recently Mulpuri was VP of lab operations for Assurex Health, and he has held various leadership positions at Catholic Health Initiatives Center for Translational Research, Beckman Coulter Genomics, and Cogenics.


Dutch molecular diagnostics company SkylineDx picked members of its scientific advisory board.

SkylineDx's newly formed SAB include Andrzej Jakubowiak, a professor of medicine and director of the University of Chicago's myeloma program; Shaji Kumar, a professor of medicine at the Mayo Clinic College of Medicine; Sagar Lonial, a trained bone marrow transplant physician with an interest in molecular therapy for lymphoma and myeloma; Gareth Morgan, director of the Myeloma Institute at the University of Arkansas for Medical Sciences; Antonio Palumbo, chief of the myeloma unit of the department of oncology at the University of Torino in Italy; David Siegel, chief of the division of multiple myeloma at Hackensack University Medical Center; Pieter Sonneveld, head of the department of hematology at Erasmus MC; and Keith Stewart, dean for research at the Mayo Clinic in Arizona.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.